Unknown

Dataset Information

0

Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.


ABSTRACT: A structure-activity relationship study of dorsomorphin, a previously identified inhibitor of SMAD 1/5/8 phosphorylation by bone morphogenetic protein (BMP) type 1 receptors ALK2, 3, and 6, revealed that increased inhibitory activity could be accomplished by replacing the pendent 4-pyridine ring with 4-quinoline. The activity contributions of various nitrogen atoms in the core pyrazolo[1,5-a]pyrimidine ring were also examined by preparing and evaluating pyrrolo[1,2-a]pyrimidine and pyrazolo[1,5-a]pyridine derivatives. In addition, increased mouse liver microsome stability was achieved by replacing the ether substituent on the pendent phenyl ring with piperazine. Finally, an optimized compound 13 (LDN-193189 or DM-3189) demonstrated moderate pharmacokinetic characteristics (e.g., plasma t(1/2)=1.6h) following intraperitoneal administration in mice. These studies provide useful molecular probes for examining the in vivo pharmacology of BMP signaling inhibition.

SUBMITTER: Cuny GD 

PROVIDER: S-EPMC2570262 | biostudies-literature | 2008 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.

Cuny Gregory D GD   Yu Paul B PB   Laha Joydev K JK   Xing Xuechao X   Liu Ji-Feng JF   Lai Carol S CS   Deng Donna Y DY   Sachidanandan Chetana C   Bloch Kenneth D KD   Peterson Randall T RT  

Bioorganic & medicinal chemistry letters 20080627 15


A structure-activity relationship study of dorsomorphin, a previously identified inhibitor of SMAD 1/5/8 phosphorylation by bone morphogenetic protein (BMP) type 1 receptors ALK2, 3, and 6, revealed that increased inhibitory activity could be accomplished by replacing the pendent 4-pyridine ring with 4-quinoline. The activity contributions of various nitrogen atoms in the core pyrazolo[1,5-a]pyrimidine ring were also examined by preparing and evaluating pyrrolo[1,2-a]pyrimidine and pyrazolo[1,5-  ...[more]

Similar Datasets

| S-EPMC10659538 | biostudies-literature
| S-EPMC4440832 | biostudies-literature
| S-EPMC8060280 | biostudies-literature
| S-EPMC2903268 | biostudies-literature
| S-EPMC3089554 | biostudies-literature
| S-EPMC2825290 | biostudies-literature
| S-EPMC6398139 | biostudies-literature
| S-EPMC4314204 | biostudies-literature
| S-EPMC5509488 | biostudies-literature
| S-EPMC3448977 | biostudies-literature